10% 2-OHp-b-cyclodextrin

• Description:

  2-OHp-b-cyclodextrin 10%_x000D_ Catalog number: K1010005D_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 25 mL_x000D_ Molecular Weight or Concentration: 10% (w/v)_x000D_ Supplied as: Solution_x000D_ Applications: versatile tools in molecular assemblies, enhancement of solubility and organic synthesis_x000D_ Storage: 2-8°C_x000D_ Keywords: (2-hydroxypropyl)-b-cyclodextrin, (2-hydroxypropyl)-β-cyclodextrin_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Sun H, Zong H, Wu G. 2‑Hydroxypropyl‑β‑cyclodextrin blocks autophagy flux and_x000D_ triggers caspase‑8‑mediated apoptotic cascades in HepG2 cells. Mol Med Rep. 2020_x000D_ Sep;22(3):1901-1909._x000D_ _x000D_ 2: Kao ML, Stellar S, Solon E, Lordi A, Kasica N, Swain G, Bagel JH, Gurda BL,_x000D_ Vite CH. Pharmacokinetics and distribution of 2-hydroxypropyl-β-cyclodextrin_x000D_ following a single intrathecal dose to cats. J Inherit Metab Dis. 2020_x000D_ May;43(3):618-634._x000D_ _x000D_ 3: Leonis G, Christodoulou E, Ntountaniotis D, Chatziathanasiadou MV,_x000D_ Mavromoustakos T, Naziris N, Chountoulesi M, Demetzos C, Valsami G, Damalas DE,_x000D_ Tzakos AG, Thomaidis NS, Karageorgos V, Liapakis G. Antihypertensive activity_x000D_ and molecular interactions of irbesartan in complex with 2-hydroxypropyl-β-_x000D_ cyclodextrin. Chem Biol Drug Des. 2020 Jul;96(1):668-683._x000D_ _x000D_ 4: Ding Y, Pang Y, Vara Prasad CVNS, Wang B. Formation of inclusion complex of_x000D_ enrofloxacin with 2-hydroxypropyl-β-cyclodextrin. Drug Deliv. 2020_x000D_ Dec;27(1):334-343._x000D_ _x000D_ 5: Pons-Faudoa FP, Sizovs A, Di Trani N, Paez-Mayorga J, Bruno G, Rhudy J,_x000D_ Manohar M, Gwenden K, Martini C, Chua CYX, Varchi G, Marzinke MA, Grattoni A._x000D_ 2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a_x000D_ nanofluidic implant for HIV pre-exposure prophylaxis. J Control Release. 2019_x000D_ Jul 28;306:89-96._x000D_ _x000D_ 6: Stappaerts J, Berben P, Cevik I, Augustijns P. The effect of 2-hydroxypropyl-_x000D_ β-cyclodextrin on the intestinal permeation through mucus. Eur J Pharm Sci. 2018_x000D_ Mar 1;114:238-244._x000D_ _x000D_ 7: Liu X, Ding D, Chen GD, Li L, Jiang H, Salvi R. 2-Hydroxypropyl-β-_x000D_ cyclodextrin Ototoxicity in Adult Rats: Rapid Onset and Massive Destruction of_x000D_ Both Inner and Outer Hair Cells Above a Critical Dose. Neurotox Res. 2020_x000D_ Oct;38(3):808-823._x000D_ _x000D_ 8: Yu SC, Chen TC, Hou YT, Wan L, Tsai FJ, Tsai Y. β-Sitosterol-2-hydroxypropyl-_x000D_ β-cyclodextrin inclusion complex: Characterization and inhibitory effect on_x000D_ adipogenesis in 3T3-L1 pre-adipocytes. Steroids. 2018 Dec;140:196-201._x000D_ _x000D_ 9: Burga-Sánchez J, Ferreira LEN, Volpato MC, Cabeça LF, Braga M, Fraceto LF, de_x000D_ Paula E, Groppo FC. Physicochemical characterization and cytotoxicity of_x000D_ articaine-2-hydroxypropyl-β-cyclodextrin inclusion complex. Naunyn Schmiedebergs_x000D_ Arch Pharmacol. 2020 Jul;393(7):1313-1323._x000D_ 10: Han D, Han Z, Liu L, Wang Y, Xin S, Zhang H, Yu Z. Solubility Enhancement of_x000D_ Myricetin by Inclusion Complexation with_x000D_ Heptakis-O-(2-Hydroxypropyl)-β-Cyclodextrin: A Joint Experimental and_x000D_ Theoretical Study. Int J Mol Sci. 2020 Jan 24;21(3):766. _x000D_ _x000D_ Products Related to 2-OHp-b-cyclodextrin 10% : Chemicals

• Short Description:

  Catalog Number: K1010005D (25 mL)

• Weight:

  2.6

• Length:

  3.3

• Width:

  1.2

• Height:

  1.2

• Height :

  1.2